Health Condition 1: L649- Androgenic alopecia, unspecified
Conditions
Interventions
Intervention1: Topical Polydeoxyribonucleotide (PDRN) serum: Topical PDRN serum application immediately following nanofusion (scalp
stimulation by microneedling), once weekly for 8 sessions.
Control I
Sponsors
SILPHION RESEARCH PRIVATE LIMITED
Eligibility
Inclusion criteria
Inclusion criteria: 1.Clinically diagnosed androgenetic alopecia with Hamilton Norwood grade two to grade five for men and Ludwig grade one to grade two for women. 2. Willingness to comply with protocol and follow-up visits.
Exclusion criteria
Exclusion criteria: 1. Pregnancy or lactation. 2. Known hypersensitivity to PDRN or excipients. 3. Active scalp infection or inflammatory dermatoses. 4. Concurrent hair restoration procedures, medications or supplements. 5. Systemic or autoimmune conditions influencing hair growth.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in hair density (Trichoscopy assessment).Timepoint: Baseline, Week 4, Week 8 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in Investigator Global Assessment 2. Patient Self-Assessment Questionnaire (10 point Visual Analogue Scale evaluating satisfaction with density, texture, and overall aesthetic improvement Standardized Photography (frontal, vertex, both profiles)Timepoint: Baseline, Week 4, Week 8 | — |
Countries
India
Contacts
Public ContactAnannya S
RENDER SKIN AND HAIR
Outcome results
None listed